Lv1
40 积分 2023-01-13 加入
GenSci120, a humanized PD-1 agonistic monoclonal antibody, enhances the binding of both PD-L1 and PD-L2 to PD-1, and mitigates the symptoms of GVHD in a mouse model
2天前
已完结
‘Knobs-into-holes’ engineering of antibody CH3 domains for heavy chain heterodimerization
3天前
已完结
The biology of interleukin-2 and interleukin-15: implications for cancer therapy and vaccine design
1个月前
已完结
IL-2 and IL-15 signaling complexes: different but the same
1个月前
已完结
IL-2Rα-biased agonist enhances antitumor immunity by invigorating tumor-infiltrating CD25+CD8+ T cells
2个月前
已完结
An optimized IL-12-Fc expands its therapeutic window, achieving strong activity against mouse tumors at tolerable drug doses
3个月前
已完结
A PD-L1xCD3 bispecific nanobody as a novel T-cell engager in treating PD-L1 overexpression melanoma
6个月前
已完结
Analysis of cancer drugs receiving FDA’s Accelerated Approval between 1992 and 2021
7个月前
已完结
Clinical Benefit and Regulatory Outcomes of Cancer Drugs Receiving Accelerated Approval
7个月前
已完结
Analysis of cancer drugs receiving FDA’s Accelerated Approval between 1992 and 2021
7个月前
已关闭
Reassessing the Effect of Colour on Attitude and Behavioural Intentions in Promotional Activities: The Moderating Role of Mood and Involvement
皖公网安备34019202002308
